SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-23-017087
Filing Date
2023-05-15
Accepted
2023-05-15 12:22:05
Documents
15
Period of Report
2023-05-15
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 43087
2 ex99-1.htm EX-99.1 63791
3 ex99-1_001.jpg GRAPHIC 31194
  Complete submission text file 0001493152-23-017087.txt   378309

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE biaf-20230515.xsd EX-101.SCH 3990
5 XBRL DEFINITION FILE biaf-20230515_def.xml EX-101.DEF 26626
6 XBRL LABEL FILE biaf-20230515_lab.xml EX-101.LAB 36673
7 XBRL PRESENTATION FILE biaf-20230515_pre.xml EX-101.PRE 25250
9 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 5576
Mailing Address 22211 WEST INTERSTATE-10 SUITE 1206 SAN ANTONIO TX 78257
Business Address 22211 WEST INTERSTATE-10 SUITE 1206 SAN ANTONIO TX 78257 210-698-5334
bioAffinity Technologies, Inc. (Filer) CIK: 0001712762 (see all company filings)

IRS No.: 465211056 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41463 | Film No.: 23920143
SIC: 8731 Services-Commercial Physical & Biological Research